June 20/27, 2017 Circulation. 2017; 135: e1145–e1158. DOI: 10.1161/CIR.
0000000000000507 e1146 be instructed to bring this equipment and contact information for …

The left ventricular assist device was originally designed to be surgically implanted as a
bridge to transplantation for patients with chronic end-stage heart failure. On the basis of the …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

OBJECTIVE To assess the benefit of proactive palliative medicine consultation for
delineation of goals of care and quality-of-life preferences before implantation of left …

BACKGROUND:: The use of left ventricular assist devices (LVADs) as destination therapy
(DT) is increasing and has proven beneficial in prolonging survival and improving quality of …

The role of palliative medicine in the care of patients with advanced heart failure, including
those who receive mechanical circulatory support, has grown dramatically in the last …

Implant ethics is defined here as the study of ethical aspects of the lasting introduction of
technological devices into the human body. Whereas technological implants relieve us of …

Left ventricular assist devices as destination therapy (DT) improve quality of life for many
patients with advanced heart failure. However, DT can be associated with risks such as …

The introduction of the left ventricular assist device as a destination therapy for patients with
heart failure introduces several ethical issues. These issues are discussed to help …

Objectives This study's objective was to investigate compassionate ventricular assist device
deactivation (VADdeact) in children from the perspective of the pediatric heart failure …